Blood molecular profile to predict genotoxicity from exposure to antineoplastic drugs.

Ladeira C, Araújo R, Ramalhete L, Teixeira H, Calado CRC

Open source

DOI
10.1016/j.mrgentox.2023.503681
Published
2023 Oct
Container
Mutation research. Genetic toxicology and environmental mutagenesis
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.mrgentox.2023.503681,
  title = {Blood molecular profile to predict genotoxicity from exposure to antineoplastic drugs.},
  author = {Ladeira C and Araújo R and Ramalhete L and Teixeira H and Calado CRC},
  year = {2023},
  journal = {Mutation research. Genetic toxicology and environmental mutagenesis},
  doi = {10.1016/j.mrgentox.2023.503681},
  url = {https://doi.org/10.1016/j.mrgentox.2023.503681}
}

RIS

TY  - JOUR
TI  - Blood molecular profile to predict genotoxicity from exposure to antineoplastic drugs.
AU  - Ladeira C
AU  - Araújo R
AU  - Ramalhete L
AU  - Teixeira H
AU  - Calado CRC
PY  - 2023
JO  - Mutation research. Genetic toxicology and environmental mutagenesis
DO  - 10.1016/j.mrgentox.2023.503681
UR  - https://doi.org/10.1016/j.mrgentox.2023.503681
ER  - 

APA

C, L., R, A., L, R., H, T., & CRC, C. (2023). Blood molecular profile to predict genotoxicity from exposure to antineoplastic drugs.. Mutation research. Genetic toxicology and environmental mutagenesis. https://doi.org/10.1016/j.mrgentox.2023.503681

Source records